Rating History for Keros Therapeutics (KROS) by Wells Fargo

More Stocks Rated by Wells Fargo | Latest Ratings for KROS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/5/2026 Ben Burnett Maintain Overweight
(Overweight)		 20.00
(23.00)		  
 		   Details